Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polypharmacy among COVID-19 patients: A systematic review
Sorochi Iloanusi, Osaro Mgbere, Ekere James Essien
Journal of the American Pharmacists Association (2021) Vol. 61, Iss. 5, pp. e14-e25
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA
Maria Mazzitelli, Mattia Trunfio, Lolita Sasset, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 493-493
Open Access | Times Cited: 31
Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115321-115321
Open Access | Times Cited: 19
Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
Jesús Cebrino, Silvia Portero de la Cruz
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Vision-and-Language Pretrained Models: A Survey
Siqu Long, Feiqi Cao, Soyeon Caren Han, et al.
Proceedings of the Thirty-First International Joint Conference on Artificial Intelligence (2022), pp. 5530-5537
Open Access | Times Cited: 24
Recent development of machine learning models for the prediction of drug-drug interactions
Eujin Hong, Junhyeok Jeon, Hyun Uk Kim
Korean Journal of Chemical Engineering (2023) Vol. 40, Iss. 2, pp. 276-285
Open Access | Times Cited: 14
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, et al.
Hypertension Research (2024) Vol. 47, Iss. 7, pp. 1943-1951
Closed Access | Times Cited: 4
Inappropriate polypharmacy during the COVID-19 pandemic: impact, challenges, and solutions – a narrative review
Evelina Gavazova, Radiana Staynova, Daniela Grekova
Folia Medica (2025) Vol. 67, Iss. 1
Open Access
Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies
Hooman Ghasemi, Niloofar Darvishi, Nader Salari, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 18
Pharmacological Adherence Behavior Changes during COVID-19 Outbreak in a Portugal Patient Cohort
Luís Midão, Marta Almada, Joana Carrilho, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1135-1135
Open Access | Times Cited: 15
Trends in Excess Winter Mortality (EWM) from 1900/01 to 2019/20—Evidence for a Complex System of Multiple Long-Term Trends
Rod Jones, Andrey Ponomarenko
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 6, pp. 3407-3407
Open Access | Times Cited: 15
Exploring the associations between polypharmacy and COVID-19-related hospitalisations and deaths: a population-based cohort study among older adults in Quebec, Canada
Caroline Sirois, Véronique Boiteau, Yohann Chiu, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e060295-e060295
Open Access | Times Cited: 13
Baseline drug treatments and long-term outcomes in COVID-19-hospitalized patients: results of the 2020 AUTCOV study
Alexandra Gráf, Berthold Reichardt, Christine Wagenlechner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis, Πέτρος Ιωάννου, Sotiris Tzalis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7172-7172
Open Access | Times Cited: 9
Predicting polypharmacy in half a million adults in the Iranian population: comparison of machine learning algorithms
Maryam Seyedtabib, Naser Kamyari
BMC Medical Informatics and Decision Making (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Mortality Prediction of COVID-19 in Hospitalized Patients Using the 2020 Diagnosis Procedure Combination Administrative Database of Japan
Shuko Nojiri, Yoshiki Irie, Rie Kanamori, et al.
Internal Medicine (2022) Vol. 62, Iss. 2, pp. 201-213
Open Access | Times Cited: 8
Polypharmacy and the In Silico Prediction of Potential Body Proteins Targeted by These Drugs Among Hospitalized COVID-19 Patients With Cytokine Storm
Ghazwan A. M. Raouf, F. K. Mohammad, Muayad Aghali Merza
Cureus (2023)
Open Access | Times Cited: 4
Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients
Essy Mozaffari, Aastha Chandak, Andrew Ustianowski, et al.
Clinical Therapeutics (2024)
Open Access | Times Cited: 1
Polypharmacy in the Hospitalized Older Adult
Analiese DiConti-Gibbs, Kimberly Y Chen, Charles Edward Coffey
Clinics in Geriatric Medicine (2022) Vol. 38, Iss. 4, pp. 667-684
Closed Access | Times Cited: 7
Trends in Excess Winter Mortality (EWM) From 1900/01 to 2019/20—Evidence for a Complex System of Multiple Long-Term Trends
Rod Jones, Andrey Ponomarenko
(2022)
Open Access | Times Cited: 6
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
Jingjing Huang, Zhaokang Zhang, Chenxia Hao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy
Kevin Bliek-Bueno, Sara Mucherino, Beatriz Poblador‐Plou, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 11786-11786
Open Access | Times Cited: 8
Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic
Marianna Capecci, Nicolò Baldini, Francesca Campignoli, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 1126-1126
Open Access | Times Cited: 3
Staging of COVID-19 disease; using selected laboratory profiles for prediction, prevention and management of severe SARS-CoV-2 infection in Africa–review
Hakim Sendagire, Steven M. Kiwuwa, Ali Dhamani, et al.
African Health Sciences (2023) Vol. 23, Iss. 1, pp. 1-15
Open Access | Times Cited: 3
Poor regulation, desperation, and misinformation, a countrywide analysis of self-medication and prescription patterns in Ecuador during the COVID-19 pandemic
Esteban Ortiz‐Prado, Juan S. Izquierdo‐Condoy, Carla Mora, et al.
Research in Social and Administrative Pharmacy (2023) Vol. 19, Iss. 12, pp. 1579-1589
Open Access | Times Cited: 3
Potential for Drug Interactions and Polypharmacy From Treatment of COVID-19 in Long-Term Care
Amie Taggart Blaszczyk, Katherine Sandlin, Sumeen Mirza, et al.
Journal of the American Medical Directors Association (2022) Vol. 23, Iss. 6, pp. 949-950
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top